Validation of the Thrombolysis in Myocardial Infarction (TIMI) risk index for predicting early mortality in a population-based cohort of STEMI and non-STEMI patients

BACKGROUND: The Thrombolysis In Myocardial Infarction (TIMI) risk index for the prediction of 30-day mortality was developed and validated in patients with ST-segment elevation myocardial infarction (STEMI) who were being treated with thrombolytics in randomized clinical trials. When tested in clini...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bradshaw, Pamela J, Ko, Dennis T, Newman, Alice M, Donovan, Linda R, Tu, Jack V
Format: Artigo
Jezik:Inglês
Izdano: Pulsus Group Inc 2007
Teme:
Clinical Studies
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2649172/
https://ncbi.nlm.nih.gov/pubmed/17245483
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items